ArticleNeuro-oncology advances

Assessing the clinical benefit from medical therapies in CNS malignancies: Refining the ESMO Magnitude of Clinical Benefit Scale and the ASCO Value Framework.

Sylvia C Kurz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.